Insider filing · NBIX
William H Rastetter
Director
profile →
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
William H Rastetter sold $3.3M of Neurocrine Biosciences (NBIX)
Executed May 5 2025, disclosed May 7 2025, 2 days later.
Value, as filed
$3.3M
30,000 sh × $110.20
Executed
May 5 2025
the trade date, as filed
Disclosed
May 7 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
WRWilliam H Rastetter (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $3.3M of NBIX (30,000 sh × $110.20, as filed), executed May 5 2025.
The name
NBIXHealthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by William H Rastetter in NBIX
NBIXSALE
Neurocrine Biosciences, Inc.
$2.7M18,000 sh × $151.82
Exec Nov 5 2025
Filed Nov 6 2025 · 5:30 PM ET